Background: Diabetes mellitus (DM) is a chronic metabolic disorder characterised by high blood sugar (BS) levels due to im- paired insulin production or insulin resistance. It is a global health concern with significant implications for morbidity and mortality. Persian medicine has long utilised natural remedies, such as Pistacia atlantica Desf., for various diseases. In this ran- domised clinical trial, the effects of P. atlantica oleoresin in the improvement of lipid profiles, glucose indices and blood pressure (BP) were assessed in patients with Type 2 DM. Materials and Methods: In this randomised, single-blind, placebo-controlled study, 42 patients with Type 2 DM were ran- domly allocated to receive either P. atlantica oleoresin or placebo capsule for 3 months. Patients were evaluated prior to and 12 weeks after the beginning of the intervention, in terms of changes in lipid profiles, glucose indices and BP. Results: After 3 months, the mean BP in patients with DM receiving P. atlantica oleoresin was sign
Evaluation of the Effect of Pistacia atlantica Oleoresin on Blood Sugar, Pressure and Lipids in Patients With Type 2 Diabetes: A Single-Blind, Placebo-Controlled Trial / Tatari, Mahin. - In: ENDOCRINOLOGY, DIABETES & METABOLISM. - ISSN 2398-9238. - 7:4(2024), pp. 1-8. [10.1002/edm2.504]
Evaluation of the Effect of Pistacia atlantica Oleoresin on Blood Sugar, Pressure and Lipids in Patients With Type 2 Diabetes: A Single-Blind, Placebo-Controlled Trial
Mahin TatariSecondo
Formal Analysis
2024
Abstract
Background: Diabetes mellitus (DM) is a chronic metabolic disorder characterised by high blood sugar (BS) levels due to im- paired insulin production or insulin resistance. It is a global health concern with significant implications for morbidity and mortality. Persian medicine has long utilised natural remedies, such as Pistacia atlantica Desf., for various diseases. In this ran- domised clinical trial, the effects of P. atlantica oleoresin in the improvement of lipid profiles, glucose indices and blood pressure (BP) were assessed in patients with Type 2 DM. Materials and Methods: In this randomised, single-blind, placebo-controlled study, 42 patients with Type 2 DM were ran- domly allocated to receive either P. atlantica oleoresin or placebo capsule for 3 months. Patients were evaluated prior to and 12 weeks after the beginning of the intervention, in terms of changes in lipid profiles, glucose indices and BP. Results: After 3 months, the mean BP in patients with DM receiving P. atlantica oleoresin was signFile | Dimensione | Formato | |
---|---|---|---|
Memariani_evaluation_2024.pdf
accesso aperto
Tipologia:
Documento in Post-print (versione successiva alla peer review e accettata per la pubblicazione)
Licenza:
Tutti i diritti riservati (All rights reserved)
Dimensione
283.46 kB
Formato
Adobe PDF
|
283.46 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.